KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Current Assets (2016 - 2025)

Amgen (AMGN) has 17 years of Current Assets data on record, last reported at $27.9 billion in Q3 2025.

  • For Q3 2025, Current Assets rose 4.18% year-over-year to $27.9 billion; the TTM value through Sep 2025 reached $27.9 billion, up 4.18%, while the annual FY2024 figure was $29.0 billion, 4.29% down from the prior year.
  • Current Assets reached $27.9 billion in Q3 2025 per AMGN's latest filing, up from $26.7 billion in the prior quarter.
  • Across five years, Current Assets topped out at $48.5 billion in Q3 2023 and bottomed at $18.5 billion in Q1 2022.
  • Average Current Assets over 5 years is $28.0 billion, with a median of $26.8 billion recorded in 2024.
  • Peak YoY movement for Current Assets: surged 145.21% in 2023, then plummeted 44.79% in 2024.
  • A 5-year view of Current Assets shows it stood at $19.4 billion in 2021, then increased by 14.45% to $22.2 billion in 2022, then soared by 36.72% to $30.3 billion in 2023, then fell by 4.29% to $29.0 billion in 2024, then decreased by 3.94% to $27.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $27.9 billion in Q3 2025, $26.7 billion in Q2 2025, and $26.9 billion in Q1 2025.